Clifford Chance Guides Cinven's $589M Pharma Co. Buy

Law360, New York (October 15, 2012, 1:57 PM EDT) -- Private equity-backed Cinven Partners LLP has acquired international drug manufacturer Amdipharm Group from its private owners for about £367 million ($589.5 million), in its second major move this year in the pharmaceutical business, Cinven announced Monday.

Per an agreement, the acquisition will be financed by a mix of deb and cash, Rebecca Flower, a spokeswoman for Cinven, told Law360. The deal will leave Amdipharm's founders with a significant, but unspecified stake, according to Cinven.

While the company will continue to operate as a stand-alone business immediately...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.